Cardiovascular risks associated with protease inhibitors for the treatment of HIV.
2021
Introduction: Cumulative use of some first-generation protease inhibitors has been associated with higher rates of dyslipidemia and increased risk of cardiovascular disease. The protease inhibitors...
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
101
References
0
Citations
NaN
KQI